MEDILUKSAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 34,164 | 50,393 | 40,111 | 16,073 | 41,040 | 42,973 | 34,063 | 38,626 |
| Profit before tax | - | -25,579 | -8,392 | -12,778 | - | -27,156 | -9,800 | -34,592 |
| Net profit | -13,159 | -25,579 | -8,392 | -12,778 | -26,185 | -27,156 | -9,800 | -34,592 |
| Equity | -29,776 | -54,990 | -62,327 | -75,105 | -101,372 | -125,932 | -100,767 | -95,398 |
| Liabilities | 23,950 | 59,744 | 63,977 | 89,008 | 115,041 | 138,387 | 123,088 | 111,307 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | -5,826 | 4,604 | 706 | 5,792 | 5,818 | 4,611 | 22,321 | 15,355 |
| Total assets | -5,826 | 4,604 | 706 | 5,792 | 5,818 | 4,611 | 22,321 | 15,355 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,866 | 1,519 | 1,958 |
| Social insurance contributions | - | - | - | - | - | 338 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +72.4% | +47.5% | -20.4% | -59.9% | +155.3% | +4.7% | -20.7% | +13.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | -555.6% | -1188.7% | -220.6% | -450.1% | -588.9% | -43.9% | -225.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -38.5% | -50.8% | -20.9% | -79.5% | -63.8% | -63.2% | -28.8% | -89.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -50.8% | -20.9% | -79.5% | - | -63.2% | -28.8% | -89.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 10,789 | 16,344 | 13,370 | 5,213 | 16,416 | 19,099 | 14,095 | 18,541 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDILUKSAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 514.52 |
| 2026-08-19 | 2026-08-19 | 514.52 |
| 2026-05-17 | 2026-05-17 | 488.32 |
| 2026-03-29 | 2026-04-06 | 3.52 |
| 2026-03-15 | 2026-03-27 | 3.52 |
| 2026-02-18 | 2026-03-11 | 3.52 |
| 2026-01-16 | 2026-02-16 | 3.52 |
| 2024-12-17 | 2024-12-17 | 451.62 |
| 2024-04-16 | 2024-05-13 | 1.01 |
| 2024-01-16 | 2024-01-16 | 444.69 |
| 2024-01-15 | 2024-01-15 | 25.74 |
| 2023-12-18 | 2024-01-11 | 25.74 |
| 2023-11-16 | 2023-11-19 | 236.29 |
| 2023-10-17 | 2023-11-15 | 30.00 |
| 2023-08-17 | 2023-08-20 | 400.34 |
| 2023-07-21 | 2023-08-16 | 1.88 |
| 2023-07-18 | 2023-07-20 | 400.29 |
| 2023-06-16 | 2023-07-17 | 1.84 |
| 2023-05-17 | 2023-06-13 | 1.84 |
| 2023-05-16 | 2023-05-16 | 414.90 |
| 2023-05-04 | 2023-05-15 | 1.84 |
| 2023-01-17 | 2023-01-18 | 98.10 |
| 2022-12-16 | 2022-12-21 | 354.60 |
| 2022-10-18 | 2022-11-14 | 270.00 |
| 2022-09-20 | 2022-10-12 | 540.00 |
| 2022-09-16 | 2022-09-19 | 1154.32 |
| 2022-08-23 | 2022-09-15 | 810.00 |
| 2022-08-16 | 2022-08-22 | 466.42 |
| 2022-07-18 | 2022-08-15 | 1080.00 |
| 2022-07-14 | 2022-07-17 | 725.26 |
| 2022-06-16 | 2022-07-13 | 1350.00 |
| 2022-06-14 | 2022-06-15 | 932.22 |
| 2022-05-25 | 2022-06-13 | 1620.00 |
| 2022-05-23 | 2022-05-24 | 1640.13 |
| 2022-05-17 | 2022-05-22 | 2385.39 |
| 2022-05-02 | 2022-05-16 | 1910.13 |
| 2022-04-22 | 2022-05-01 | 1910.13 |
| 2022-04-19 | 2022-04-21 | 2685.49 |
| 2022-04-04 | 2022-04-18 | 2180.12 |
| 2022-03-22 | 2022-04-03 | 2180.12 |
| 2022-03-16 | 2022-03-21 | 2659.77 |
| 2022-03-15 | 2022-03-15 | 2178.86 |
| 2022-03-02 | 2022-03-14 | 2448.86 |
| 2022-02-23 | 2022-03-01 | 2448.86 |
| 2022-02-17 | 2022-02-22 | 2928.51 |
| 2022-02-02 | 2022-02-16 | 2718.86 |
| 2022-01-18 | 2022-02-01 | 2718.86 |
| 2022-01-17 | 2022-01-17 | 2309.91 |
| 2021-12-17 | 2022-01-16 | 2970.24 |
| 2021-12-16 | 2021-12-16 | 3676.47 |
| 2021-11-16 | 2021-12-15 | 3240.24 |
| 2021-11-15 | 2021-11-15 | 2822.98 |
| 2021-11-05 | 2021-11-14 | 3510.24 |
| 2021-11-03 | 2021-11-04 | 3782.82 |
| 2021-10-18 | 2021-11-02 | 3782.82 |
| 2021-10-14 | 2021-10-17 | 3365.56 |
| 2021-09-16 | 2021-10-13 | 3782.82 |
MEDILUKSAS - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company MEDILUKSAS is: 6,882 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 6881.65 |
| 2026-08-31 | 2026-08-31 | 6879.89 |
| 2026-08-28 | 2026-08-30 | 6872.85 |
| 2026-08-25 | 2026-08-27 | 7419.98 |
| 2026-08-20 | 2026-08-24 | 7164.14 |
| 2026-08-19 | 2026-08-19 | 222.02 |
| 2026-08-18 | 2026-08-18 | 222.03 |
| 2026-08-14 | 2026-08-17 | 220.66 |
| 2026-07-07 | 2026-07-07 | 28.66 |
| 2025-04-04 | 2025-04-04 | 82.15 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDILUKSAS, UAB (code 301005747) is a Private Limited Liability Company engaged in restaurant activities. In 2025, revenue increased to €38.6K from €34.1K in 2024, showing a moderate year-on-year improvement, while it remained below the €43.0K achieved in 2023. Despite higher sales, profitability weakened sharply: net loss widened to €34.6K in 2025 from €9.8K in 2024, and the profit margin fell to -89.6%. Over the 2023–2025 period, revenue declined from 2023 to 2024 and then partially recovered in 2025, but losses persisted throughout the period.
The balance sheet remained weak in 2025, with total assets of €15.4K, equity of -€95.4K and liabilities of €111.3K. Negative equity indicates a strained capital structure, so ratios linked to equity should be interpreted cautiously. Asset turnover was 2.52x, indicating revenue generation from a small asset base. Revenue per employee was €19.3K, while profit per employee was -€17.3K, reflecting continued operating pressure.
The balance sheet remained weak in 2025, with total assets of €15.4K, equity of -€95.4K and liabilities of €111.3K. Negative equity indicates a strained capital structure, so ratios linked to equity should be interpreted cautiously. Asset turnover was 2.52x, indicating revenue generation from a small asset base. Revenue per employee was €19.3K, while profit per employee was -€17.3K, reflecting continued operating pressure.